Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1981 Dec 1;199(3):619–627. doi: 10.1042/bj1990619

Hydrophobic-interaction chromatography and anion-exchange chromatography in the presence of acetonitrile. A two-step purification method for human prolactin

Steven C Hodgkinson 1,*, Philip J Lowry 1
PMCID: PMC1163418  PMID: 7340823

Abstract

Described is a two-chromatographic-step preparative-scale technique for the purification of human prolactin from a frozen pituitary homogenate. The method utilizes hydrophobic interaction chromatography on the mildly hydrophobic adsorbent phenyl-Sepharose CL-4B and anion-exchange chromatography on DEAE-cellulose in the presence of acetonitrile. Human prolactin was solubilized at pH10.0 after a prior extraction of pituitaries at pH4.0, the acid pH being ineffective at solubilizing human prolactin but capable of solubilizing large amounts of interfering protein. An 11-fold increase in the potency of the solubilized human prolactin was achieved in this manner. Prolactin could be adsorbed to phenyl-Sepharose at low ionic strengths (I<0.01); few other proteins were adsorbed under these conditions. This is a demonstration of the hydrophobic nature of human prolactin. The amount of phenyl-Sepharose was limited to the minimum (35mg of protein/g of phenyl-Sepharose) necessary to adsorb human prolactin, further reducing the uptake of other pituitary protein. Desorption was achieved by using an acetonitrile gradient (0–30%, v/v), resulting in a purification of human prolactin of 85-fold and recovery of 78%. Acetonitrile (20%, v/v) was also included in all buffers for DEAE-cellulose chromatography, increasing the resolution and recovery of human prolactin, apparently by minimizing non-ionic interactions with the matrix. Prolactin (10mg) was recovered from 63g if pituitaries, an overall recovery of 58%. It was homogeneous by gel filtration and sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, contained less than 0.1% somatotropin (growth hormone), on iodination demonstrated more than 95% binding to excess anti-(human prolactin) serum and could be displaced from anti-(human prolactin) serum in a manner indistinguishable from the serum of a patient with a human prolactin-secreting adenoma.

Full text

PDF
619

Images in this article

626Fig. 4.
on p.626

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-David M., Chrambach A. Preparation of bio- and immunoactive human prolactin in milligram amounts from amniotic fluid in 60% yield. Endocrinology. 1977 Jul;101(1):250–261. doi: 10.1210/endo-101-1-250. [DOI] [PubMed] [Google Scholar]
  2. Bewley T. A., Li C. H. Primary structures of human pituitary growth hormone and sheep pituitary lactogenic hormone compared. Science. 1970 Jun 12;168(3937):1361–1362. doi: 10.1126/science.168.3937.1361. [DOI] [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  4. Canfield C. J., Bates R. W. Nonpuerperal galactorrhea. N Engl J Med. 1965 Oct 21;273(17):897–902. doi: 10.1056/NEJM196510212731703. [DOI] [PubMed] [Google Scholar]
  5. Donald R. A., Espiner E. A., Hodgkinson S. C., Evans K. Measurement of pituitary hormones: clinical applications. 5. Prolactin. N Z Med J. 1976 Jun 23;83(566):431–435. [PubMed] [Google Scholar]
  6. Forsyth I. A., Buntin J. D., Nicoll C. S. A pigeon crop sac radioreceptor assay for prolactin. J Endocrinol. 1978 Dec;79(3):349–356. doi: 10.1677/joe.0.0790349. [DOI] [PubMed] [Google Scholar]
  7. Forsyth I. A., Myres R. P. Human prolactin. Evidence obtained by the bioassay of human plasma. J Endocrinol. 1971 Sep;51(1):157–168. doi: 10.1677/joe.0.0510157. [DOI] [PubMed] [Google Scholar]
  8. Friesen H., Guyda H., Hardy J. The biosynthesis of human growth hormone and prolactin. J Clin Endocrinol Metab. 1970 Dec;31(6):611–624. doi: 10.1210/jcem-31-6-611. [DOI] [PubMed] [Google Scholar]
  9. Friesen H., Hwang P. Human prolactin. Annu Rev Med. 1973;24:251–270. doi: 10.1146/annurev.me.24.020173.001343. [DOI] [PubMed] [Google Scholar]
  10. Guyda H., Hwang P., Friesen H. Immunologic evidence for monkey and human prolactin (MPr and HPr). J Clin Endocrinol Metab. 1971 Jan;32(1):120–123. doi: 10.1210/jcem-32-1-120. [DOI] [PubMed] [Google Scholar]
  11. Hummel B. C., Brown G. M., Hwang P., Friesen H. G. Human and monkey prolactin and growth hormone: separation of polymorphic forms by isoelectric focusing. Endocrinology. 1975 Oct;97(4):855–867. doi: 10.1210/endo-97-4-855. [DOI] [PubMed] [Google Scholar]
  12. Hwang P., Guyda H., Friesen H. Purification of human prolactin. J Biol Chem. 1972 Apr 10;247(7):1955–1958. [PubMed] [Google Scholar]
  13. Hwang P., Guyda H., Friesen H. Purification of human prolactin. Methods Enzymol. 1975;37:389–402. doi: 10.1016/s0076-6879(75)37034-1. [DOI] [PubMed] [Google Scholar]
  14. Jones R. L., Benker G., Salacinski P. R., Lloyd T. J., Lowry P. J. Large-scale preparation of highly purified pyrogen-free human growth hormone for clinical use. J Endocrinol. 1979 Jul;82(1):77–86. doi: 10.1677/joe.0.0820077. [DOI] [PubMed] [Google Scholar]
  15. Kamel R. S., Landon J., Smith D. S. Novel 125I-labeled nortriptyline derivatives and their use in liquid-phase or magnetizable solid-phase second-antibody radioimmunoassays. Clin Chem. 1979 Dec;25(12):1997–2002. [PubMed] [Google Scholar]
  16. Kleinberg D. L., Frantz A. G. Human prolactin: measurement in plasma by in vitro bioassay. J Clin Invest. 1971 Aug;50(8):1557–1568. doi: 10.1172/JCI106643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lewis U. J. Chemistry of prolactin. Adv Exp Med Biol. 1977;80:19–35. doi: 10.1007/978-1-4615-6675-5_2. [DOI] [PubMed] [Google Scholar]
  18. Lewis U. J., Singh R. N., Seavey B. K. Human prolactin: isolation and some properties. Biochem Biophys Res Commun. 1971 Sep;44(5):1169–1176. doi: 10.1016/s0006-291x(71)80209-7. [DOI] [PubMed] [Google Scholar]
  19. Marchalonis J. J. An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J. 1969 Jun;113(2):299–305. doi: 10.1042/bj1130299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mittra I. A novel "cleaved prolactin" in the rat pituitary: part I. Biosynthesis, characterization and regulatory control. Biochem Biophys Res Commun. 1980 Aug 29;95(4):1750–1759. doi: 10.1016/s0006-291x(80)80101-x. [DOI] [PubMed] [Google Scholar]
  21. Pourfarzaneh M., White G. W., Landon J., Smith D. S. Cortisol directly determined in serum by fluoroimmunoassay with magnetizable solid phase. Clin Chem. 1980 May;26(6):730–733. [PubMed] [Google Scholar]
  22. Påhlman, Rosengren J., Hjertén S. Hydrophobic interaction chromatography on uncharged Sepharose derivatives. Effects of neutral salts on the adsorption of proteins. J Chromatogr. 1977 Jan 21;131:99–108. doi: 10.1016/s0021-9673(00)80924-3. [DOI] [PubMed] [Google Scholar]
  23. Rathnam P., Saxena B. B. Recovery of prolactin from acetone-dried human pituitary glands. Endocrinology. 1977 May;100(5):1403–1408. doi: 10.1210/endo-100-5-1403. [DOI] [PubMed] [Google Scholar]
  24. Rosengren J., Pählman S., Glad M., Hjertén S. Hydrophobic interaction chromatography on non-charged Sepharose derivatives. Binding of a model protein, related to ionic strength, hydrophobicity of the substituent, and degree of substitution (determined by NMR). Biochim Biophys Acta. 1975 Nov 18;412(1):51–61. [PubMed] [Google Scholar]
  25. WILHELMI A. E. Fractionation of human pituitary glands. Can J Biochem Physiol. 1961 Nov;39:1659–1668. doi: 10.1139/o61-183. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES